Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Perez

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Expert Opinion on Emerging Drugs|July 9, 2015
Emerging treatment for advanced lung cancer with EGFR mutationCengiz Inal, Emrullah Yilmaz, Bilal Piperdi, et al.
Expert Opinion on Pharmacotherapy|March 27, 2014
Cell cycle inhibitors for the treatment of NSCLCMarina Shcherba, Yuanxin Liang, David Fernandes, et al.
Blood|July 22, 2004
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasisLiang Hu, Merlin Lee, Wendy Campbell, et al.
Expert Opinion on Investigational Drugs|March 10, 2017
Investigational therapies for squamous cell lung cancer: from animal studies to phase II trialsElaine Shum, Feng Wang, Salem Kim, et al.
Oncotarget|January 10, 2018
TRIB2 contributes to cisplatin resistance in small cell lung cancerYuanxin Liang, Dong Yu, Roman Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cellsTianhong Li, Yi-He Ling, I David Goldman, et al.
Clinical Lung Cancer|November 11, 2010
Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicitySameer Mahesh, Ashish Saxena, Xuan Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatmentYiyu Zou, Carmen Tornos, Xuan Qiu, et al.
Molecular Cancer Therapeutics|November 11, 2011
Bortezomib: understanding the mechanism of actionBilal Piperdi, Yi-He Ling, Leonard Liebes, et al.
Plos One|October 28, 2014
Aerosol azacytidine inhibits orthotopic lung cancers in mice through Its DNA demethylation and gene reactivation effectsXuan Qiu, Yuanxin Liang, Rani S Sellers, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Expert Opinion on Emerging Drugs|July 9, 2015
Emerging treatment for advanced lung cancer with EGFR mutationCengiz Inal, Emrullah Yilmaz, Bilal Piperdi, et al.
Expert Opinion on Pharmacotherapy|March 27, 2014
Cell cycle inhibitors for the treatment of NSCLCMarina Shcherba, Yuanxin Liang, David Fernandes, et al.
Blood|July 22, 2004
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasisLiang Hu, Merlin Lee, Wendy Campbell, et al.
Expert Opinion on Investigational Drugs|March 10, 2017
Investigational therapies for squamous cell lung cancer: from animal studies to phase II trialsElaine Shum, Feng Wang, Salem Kim, et al.
Oncotarget|January 10, 2018
TRIB2 contributes to cisplatin resistance in small cell lung cancerYuanxin Liang, Dong Yu, Roman Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cellsTianhong Li, Yi-He Ling, I David Goldman, et al.
Clinical Lung Cancer|November 11, 2010
Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicitySameer Mahesh, Ashish Saxena, Xuan Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatmentYiyu Zou, Carmen Tornos, Xuan Qiu, et al.
Molecular Cancer Therapeutics|November 11, 2011
Bortezomib: understanding the mechanism of actionBilal Piperdi, Yi-He Ling, Leonard Liebes, et al.
Plos One|October 28, 2014
Aerosol azacytidine inhibits orthotopic lung cancers in mice through Its DNA demethylation and gene reactivation effectsXuan Qiu, Yuanxin Liang, Rani S Sellers, et al.
Pageof 14